NO20000484L - Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel - Google Patents

Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Info

Publication number
NO20000484L
NO20000484L NO20000484A NO20000484A NO20000484L NO 20000484 L NO20000484 L NO 20000484L NO 20000484 A NO20000484 A NO 20000484A NO 20000484 A NO20000484 A NO 20000484A NO 20000484 L NO20000484 L NO 20000484L
Authority
NO
Norway
Prior art keywords
crystalline
füä1
ethylü
dibenzoäb
hydroxyethoxy
Prior art date
Application number
NO20000484A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000484D0 (no
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO20000484D0 publication Critical patent/NO20000484D0/no
Publication of NO20000484L publication Critical patent/NO20000484L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
NO20000484A 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel NO20000484L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process
PCT/GB1998/002260 WO1999006381A1 (en) 1997-08-01 1998-07-28 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent

Publications (2)

Publication Number Publication Date
NO20000484D0 NO20000484D0 (no) 2000-01-31
NO20000484L true NO20000484L (no) 2000-03-16

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000484A NO20000484L (no) 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Country Status (31)

Country Link
US (2) US6372734B1 (cs)
EP (2) EP1000043B1 (cs)
JP (2) JP2001512109A (cs)
KR (1) KR20010022241A (cs)
CN (1) CN1125058C (cs)
AT (2) ATE444959T1 (cs)
AU (1) AU739255B2 (cs)
BG (1) BG64796B1 (cs)
BR (1) BR9811061A (cs)
CA (1) CA2295792C (cs)
CY (2) CY2200162T2 (cs)
CZ (1) CZ299225B6 (cs)
DE (4) DE69841216D1 (cs)
EE (1) EE04550B1 (cs)
ES (2) ES2296575T3 (cs)
GB (2) GB9716161D0 (cs)
HU (1) HU228620B1 (cs)
ID (1) ID24219A (cs)
IL (1) IL133618A (cs)
MY (1) MY120999A (cs)
NO (1) NO20000484L (cs)
NZ (1) NZ501914A (cs)
PL (1) PL338384A1 (cs)
PT (2) PT1589008E (cs)
RU (1) RU2224754C2 (cs)
SI (2) SI1589008T1 (cs)
SK (1) SK287145B6 (cs)
TR (1) TR200000848T2 (cs)
TW (1) TW533207B (cs)
WO (1) WO1999006381A1 (cs)
ZA (1) ZA986904B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL164155A0 (en) * 2002-03-20 2005-12-18 Teva Pharma Crystalline forms of quetiapine hemifumarate
CN1777594A (zh) * 2003-02-22 2006-05-24 特瓦制药工业有限公司 喹迪平及其可药用盐的合成
US7238686B2 (en) * 2003-03-03 2007-07-03 Hetero Drugs Limited Polymorphs of quetiapine fumarate
WO2004089957A1 (en) * 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
US7687622B2 (en) 2005-04-14 2010-03-30 Teva Pharmaceutical Industries, Ltd Process for preparing quetiapine fumarate
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
WO2007036599A1 (en) 2005-09-30 2007-04-05 Fermion Oy New crystallization process of quetiapine hemifumarate
WO2007048870A1 (en) * 2005-10-28 2007-05-03 Fermion Oy Quetiapine hemifumarate purification by crystallization
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
JP2009516705A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 塩の形態
WO2007062339A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Liquid formulations
WO2007062338A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Solid formulations
WO2007062337A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Crystalline forms
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
ATE480227T1 (de) 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
EP2144892A2 (en) * 2007-03-29 2010-01-20 Teva Pharmaceutical Industries Ltd. Improved process for preparing quetiapine fumarate
WO2009004480A2 (en) * 2007-05-07 2009-01-08 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
KR101598558B1 (ko) * 2007-12-05 2016-02-29 얀센 파마슈티카 엔.브이. 디벤조아제핀 및 디벤조옥사제핀 ｔｒｐａ1 효능제
DE202009018024U1 (de) 2008-08-01 2010-12-09 Krka Tovarna Zdravil, D.D., Novo Mesto Quetiapin-Zusammensetzung
US20100069356A1 (en) * 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
WO2010100623A1 (en) 2009-03-04 2010-09-10 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
EP3789500A1 (en) 2011-08-12 2021-03-10 QIAGEN GmbH Method for isolating nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
CN1265101A (zh) 2000-08-30
PT1589008E (pt) 2011-03-23
KR20010022241A (ko) 2001-03-15
HU228620B1 (en) 2013-04-29
PL338384A1 (en) 2000-10-23
DE05011169T1 (de) 2008-11-06
PT1000043E (pt) 2009-11-30
EE200000062A (et) 2000-10-16
RU2224754C2 (ru) 2004-02-27
CY2200162T2 (el) 2010-07-28
BG104176A (en) 2000-08-31
HK1029992A1 (en) 2001-04-20
BR9811061A (pt) 2000-09-19
ATE444959T1 (de) 2009-10-15
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
HK1081962A1 (en) 2006-05-26
SI1000043T1 (sl) 2010-01-29
BG64796B1 (bg) 2006-04-28
CA2295792A1 (en) 1999-02-11
NZ501914A (en) 2001-09-28
DE69841216D1 (de) 2009-11-19
DE98936529T1 (de) 2008-11-20
SI1589008T1 (sl) 2011-04-29
CZ2000341A3 (cs) 2000-05-17
ATE496037T1 (de) 2011-02-15
MY120999A (en) 2005-12-30
JP2001512109A (ja) 2001-08-21
HUP0002663A2 (hu) 2001-09-28
ES2296568T3 (es) 2011-05-06
TR200000848T2 (tr) 2000-08-21
AU739255B2 (en) 2001-10-04
WO1999006381A1 (en) 1999-02-11
GB9716161D0 (en) 1997-10-08
EP1589008B1 (en) 2011-01-19
HUP0002663A3 (en) 2001-10-29
EE04550B1 (et) 2005-10-17
SK1302000A3 (en) 2000-06-12
DE69842104D1 (de) 2011-03-03
NO20000484D0 (no) 2000-01-31
CY2200161T2 (el) 2010-07-28
ES2296568T1 (es) 2008-05-01
ID24219A (id) 2000-07-13
JP2009102345A (ja) 2009-05-14
ES2296575T3 (es) 2010-02-05
TW533207B (en) 2003-05-21
CZ299225B6 (cs) 2008-05-21
GB9814882D0 (en) 1998-09-09
EP1000043A1 (en) 2000-05-17
AU8549898A (en) 1999-02-22
EP1589008A1 (en) 2005-10-26
US6372734B1 (en) 2002-04-16
ES2296575T1 (es) 2008-05-01
CA2295792C (en) 2007-04-17
CN1125058C (zh) 2003-10-22
US20020147186A1 (en) 2002-10-10
EP1000043B1 (en) 2009-10-07
ZA986904B (en) 1999-02-01
SK287145B6 (sk) 2010-01-07

Similar Documents

Publication Publication Date Title
NO20000484L (no) Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
AU2002213515A1 (en) An apparatus convertible to a chair or treatment table
ES2182079T3 (es) Composiciones farmaceuticas de liberacion sostenida que contienen un derivado de dibenzotiazepina.
DK0640069T3 (da) Fluoralkenylforbindelser og deres anvendelse som midler til bekæmpelse af skadelige organismer
AU2001295926A1 (en) Process for producign optically active ethyl
NO931534D0 (no) Sulfonylbenzylsubstituerte benzo- og pyridopyridoner
NO303641B1 (no) Optisk aktive benzotiepinderivater, mellomprodukter for deres fremstilling og deres anvendelse
AU3696197A (en) Process for the recovery of crystalline beta-carotene from natural source
FI962639A0 (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
DK1075471T3 (da) Idolylderivater som serotonerge midler
AU4009497A (en) Substituted pyrazolyl-pyrazole derivatives, process for their preparation nd their use as agents with a herbicidal effect
NO20022379D0 (no) Nye tiazolidinedionderivater som antidiabetiske midler
ES2091285T3 (es) 2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina.
RU97117486A (ru) Средство для уничтожения пресноводных моллюсков
FI980947L (fi) Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi
PT1019521E (pt) Um metodo para a biotransformacao de compostos de colchicona nos derivados de 3-glicosil correspondentes
AU7641291A (en) Composition for disinfecting water by the electrochlorination process and use of this composition
AU7379794A (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists
KR940022660U (ko) 유기물 발효기용 탈취장치
DK0980383T3 (da) Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener
IT236181Y1 (it) Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta
SE9602476D0 (sv) Process for the preparation of organic salts of N'N -diacetylcystine
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine
AU3281397A (en) Process for the preparation of organic salts of n'n-diacetylcystine